Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-012865
Filing Date
2019-08-26
Accepted
2019-08-26 16:47:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33442
2 filename2.txt TEXT-EXTRACT 2551
  Complete submission text file 0000000000-19-012865.txt   49333
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filed for) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations